142 related articles for article (PubMed ID: 35632611)
1. Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.
Wang H; Davido DJ; Mostafa HH; Morrison LA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632611
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
3. Herpes Simplex Virus 1 Mutant with Point Mutations in
Mostafa HH; Thompson TW; Konen AJ; Haenchen SD; Hilliard JG; Macdonald SJ; Morrison LA; Davido DJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321311
[TBL] [Abstract][Full Text] [Related]
4. Disruption of virion host shutoff activity improves the immunogenicity and protective capacity of a replication-incompetent herpes simplex virus type 1 vaccine strain.
Geiss BJ; Smith TJ; Leib DA; Morrison LA
J Virol; 2000 Dec; 74(23):11137-44. PubMed ID: 11070010
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.
Smith TJ; Ackland-Berglund CE; Leib DA
J Virol; 2000 Apr; 74(8):3598-604. PubMed ID: 10729135
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
[TBL] [Abstract][Full Text] [Related]
7. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
9. Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication.
Bryant KF; Yan Z; Dreyfus DH; Knipe DM
J Virol; 2012 Jun; 86(12):6825-34. PubMed ID: 22491472
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus 1 ICP8 mutant lacking annealing activity is deficient for viral DNA replication.
Weerasooriya S; DiScipio KA; Darwish AS; Bai P; Weller SK
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1033-1042. PubMed ID: 30598436
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
[TBL] [Abstract][Full Text] [Related]
12. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Morrison LA; Knipe DM
J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
[TBL] [Abstract][Full Text] [Related]
13. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
14. A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.
Stanfield BA; Stahl J; Chouljenko VN; Subramanian R; Charles AS; Saied AA; Walker JD; Kousoulas KG
PLoS One; 2014; 9(10):e109890. PubMed ID: 25350288
[TBL] [Abstract][Full Text] [Related]
15. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
Augustinova H; Hoeller D; Yao F
J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
[TBL] [Abstract][Full Text] [Related]
16. ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice.
Korom M; Wang H; Bernier KM; Geiss BJ; Morrison LA
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515256
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
18. B7 costimulation molecules encoded by replication-defective, vhs-deficient HSV-1 improve vaccine-induced protection against corneal disease.
Schrimpf JE; Tu EM; Wang H; Wong YM; Morrison LA
PLoS One; 2011; 6(8):e22772. PubMed ID: 21826207
[TBL] [Abstract][Full Text] [Related]
19. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
20. An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.
Awasthi S; Lubinski JM; Eisenberg RJ; Cohen GH; Friedman HM
Vaccine; 2008 Feb; 26(9):1195-203. PubMed ID: 18243431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]